600993.SS
600993.SS
CNE000001HN2
MAYINGLONG PHARMACEUTICAL GP CO
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 3.866.608.233 3.728.023.669
3.7%
Cost of Revenue 1.964.792.797 1.992.486.630
1.4%
Gross Profit 1.901.815.436 1.735.537.039
9.6%
1.232.088.001 1.116.528.588
10.3%
Operating Income 669.727.435 619.008.451
8.2%
Pretax Income 709.000.784 657.553.692
7.8%
Net Income Common Stockholders 581.492.373 528.093.859
10.1%
-- --
--
-- --
--
ende